Reuters · Apr 2026
Humana's CenterWell Pharmacy partnered with Cost Plus Drugs to use its SwiftyRx platform, extend mail-order options, and co-develop an employer prescription solution.
Making low cost versions of high cost generic drugs.
costplusdrugs.com
Healthcare
Company research
Public company, workplace, funding, and market signals
Overview
Public-benefit, vertically integrated pharmaceutical company that sells transparent low-cost prescriptions through a direct-to-consumer online pharmacy, B2B employer/MCO offerings, wholesale distribution, and manufacturing capacity aimed at drug shortages.
Primary product
Transparent low-cost online pharmacy and prescription drug platform
Founded
2016
Headquarters
Dallas, Texas, United States
Team size
50-60
Industry
Pharmaceutical Manufacturing
Sub-industry
Online pharmacy / pharmaceutical manufacturing
Offices
2909 Taylor Street Suite A, Dallas, TX 75226, United States
Dallas, Texas, United States (22,000 sq ft sterile fill-finish manufacturing facility)
Business model
direct-to-consumer online pharmacy
business-to-business pharmacy benefits and employer/MCO programs
licensed wholesale distribution
pharmaceutical manufacturing
pharmacy SaaS / order-intake platform
Funding
Stage
Seed / generating revenue
Total raised
$1.4M
Latest round
Seed · Jan 2019
Latest amount
$1.3M
People & investors
Leadership
Co-founder
CEO / Co-founder
Chief Financial Officer
Chief Commercial Officer / Vice President - Commercial Operations
Vice President of Trade Relations & Pharmaceutical Contracting
Chief of Pharmacy Relations, Network & Professional Affairs
Chief Supply Chain Officer
Work & culture
Mission-driven, public-benefit culture centered on transparency, affordability, patient access, and cross-functional execution across manufacturing, pharmacy, and employer channels.
Product & market
Pricing
Cost-plus pricing: manufacturer acquisition cost plus a fixed 15% markup, plus pharmacy labor/dispensing and shipping charges; B2B offerings emphasize pass-through pricing with no rebates.
Differentiators
- —transparent published pricing
- —fixed low markup instead of spread pricing
- —no rebate / no offshore intermediary model
- —vertically integrated manufacturing-wholesale-pharmacy supply chain
- —public-benefit corporation structure
- —ability to address drug shortages through domestic manufacturing
- —direct-to-patient and employer/MCO channels
- —price transparency from manufacturing to delivery
Technology
Salesforce
SAP Business ByDesign
SAP Supply Chain
MasterControl
TrackWise
Microsoft 365
Google Workspace
Azure Active Directory
Hootsuite
Sprout Social
GraphiteRx
Linux
Python
GitHub
Customers
patients
cash-paying consumers
employers
managed care organizations
healthcare providers
hospitals and clinics
surgery centers
pharmacies
healthcare businesses
Competitors
GoodRx
SingleCare
Blink Health
RxSaver
Ro
traditional PBMs / pharmacy benefit managers
Scale & contact
Estimated revenue
$1B-$2B
Estimated monthly visits
1.2M
Traffic estimate as of Jun 2026
Latest news
Reuters · Apr 2026
Bristol Myers Squibb and Pfizer agreed to sell Eliquis through CostPlusDrugs.com, expanding direct-to-patient access and adding a major brand drug to the platform.
Reuters · Dec 2025
Cuban urged FDA fee relief to accelerate U.S. generic manufacturing, saying Cost Plus Drugs would expand domestic production if the regulatory burden were reduced.
Reuters · Jun 2025
Cost Plus Drugs partnered with 9amHealth to offer employer-focused obesity and chronic-condition treatment options, including access to cheaper medications.
Reuters · Jul 2024
Cost Plus Drugs worked with the FDA to import and distribute penicillin temporarily to mitigate a U.S. shortage.
Jobs and careers at Mark Cuban Cost Plus Drug Company, PBC
0 jobs at Mark Cuban Cost Plus Drug Company, PBC
No open positions
Check back later for new openings